XERSXeris Biopharma Holdings, Inc.

$982M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+58.4% YoY

Gross Profit

$2M98.3% margin

Operating Income

-$59M-2407.5% margin

Net Income

-$60M-2437.3% margin

EPS (Diluted)

$-4.99

Cash Flow

Operating Cash Flow

-$56M

Free Cash Flow

-$58M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$120M

Total Liabilities

$45M

Stockholders' Equity

$75M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+58.4%
Gross Profit	$2M	$2M	+56.1%
Operating Income	-$59M	-$27M	-122.9%
Net Income	-$60M	-$27M	-126.3%

XERS FY 2018 Earnings — Xeris Biopharma Holdings, Inc. Revenue & Financial Results | Market Cap Arena